# Durable hematopoiesis and tolerance after vertebral bone marrow transplant from a deceased lung transplant donor

**Authors:** Paul Szabolcs, Xiaohua Chen, Marian G. Michaels, Memphis Hill, Evelyn Garchar, Zarreen Amin, Heather M. Stanczak, Shawna McIntyre, Aleksandra Petrovic, Dhivyaa Rajasundaram, Ansuman Chattopadhyay, Jonathan E. Spahr, Peter D. Wearden, Geoffrey Kurland

PMC · DOI: 10.1172/jci.insight.198029 · JCI Insight · 2026-02-03

## TL;DR

A bone marrow transplant from a deceased donor's vertebral bodies successfully established long-term blood cell production and immune tolerance in a patient with severe immunodeficiency.

## Contribution

This is the first reported case of durable hematopoiesis and tolerance after vertebral bone marrow transplant from an unrelated deceased donor.

## Key findings

- Donor T cell chimerism persisted for over 9 years with stable immune function.
- Host-reactive T cell clones disappeared, and immunomodulatory pathways were upregulated.
- Host monocytes showed active interaction with donor T cells, suggesting immune tolerance mechanisms.

## Abstract

We hypothesized that bone marrow transplantation (BMT) using marrow extracted from the vertebral bodies (VBs) of an unrelated deceased lung transplant donor would be able to establish persistent hematopoiesis and generate immunity and tolerance. A teenager with severe combined immunodeficiency with lung failure due to recurrent pneumonias underwent lung transplantation in 2016 from a 1/8 HLA allele–matched unrelated donor, followed by BMT 4 months later using T cell/B cell–depleted, cryopreserved VB marrow. Rapid engraftment was followed by accelerating immune competence at 6 months, with independence from immunosuppression by 16 months. Donor T cell (>95%) and myeloid chimerism (7%–10%) has persisted for over 9 years. At 2 years after BMT, circulating T cells were hyporesponsive to host dendritic cells in vitro. T cell receptor clonotyping revealed the disappearance of host-reactive clones, and T cell RNA sequencing exhibited downmodulated signaling pathways for cytotoxicity/rejection, paired with upregulated immunomodulatory pathways, suggesting active suppression. In parallel, host monocytes upregulated certain signaling pathways, indicating active interactions between post-thymic donor T cells and host monocytes. In summary, for the first time to our knowledge, durable hematopoietic engraftment, immunity, and tolerance were demonstrable in a recipient of BMT obtained from a VB graft.

Vertebral bone marrow transplant establishes durable hemopoiesis in the first successful case, generates adaptive and innate immunity and confers tolerance between host and lung allograft.

## Linked entities

- **Diseases:** severe combined immunodeficiency (MONDO:0015974)

## Full-text entities

- **Genes:** HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}
- **Diseases:** pneumonias (MESH:D011014), severe combined immunodeficiency (MESH:D016511), cytotoxicity (MESH:D064420), lung failure (MESH:D012131)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13043083/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13043083/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC13043083/full.md

---
Source: https://tomesphere.com/paper/PMC13043083